Association between exposure to proton pump inhibitors and hypertension: a descriptive and disproportionality analysis of VigiBase. [PDF]
Chretien B +6 more
europepmc +1 more source
Safety of Potassium-Competitive Acid Blockers Compared With Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease and Peptic Ulcer Disease: A Systematic Review and Meta-Analysis. [PDF]
Jang Y +6 more
europepmc +1 more source
Vomiting, hypotonia and failure to thrive in a 12-month-old female. [PDF]
MacDonald BE, Acott PD, Burns E.
europepmc +1 more source
Comparing the Efficacy and Safety of Fexuprazan and Lansoprazole for the Prevention of Nonsteroidal Anti-inflammatory Drug-Induced Peptic Ulcer. [PDF]
Hong S +28 more
europepmc +1 more source
Festlegung von Erstattungspreisen für Arzneimittel zur Behandlung der Gastroösophagealen Refluxkrankheit: Eine Machbarkeitsstudie zur 'Modellbeschreibung und Methodik für die Festlegung von Erstattungspreis-Korridoren im generikafähigen GKV-Markt' des Bundesverbandes der Arzneimittelhersteller (BAH) [PDF]
Aidelsburger, Pamela +4 more
core
Lansoprazole associated with a relatively lower gout risk among PPI users: a nationwide retrospective study. [PDF]
Shih HK +8 more
europepmc +1 more source
Vitamin B12 Deficiency Associated with Metformin and Proton Pump Inhibitors and Their Combinations: Results from a Disproportionality and Interaction Analysis. [PDF]
Sridharan K.
europepmc +1 more source

